The markets we serve
Alfakjn distributes in 23 countries through local partners, with an established presence across four broad geographical regions: Europe, the former Soviet region, MENAT and Asia. Each region has its own specific dynamics: regulation, distribution channels, target professional profiles and commercial expectations. Our experience in international markets is not just a list of countries: it is an understanding of how distribution actually works in those contexts.
Europe: Mature markets, demanding regulation, room for quality
Alfakjn’s European distribution covers central, southern and Balkan European markets, including countries such as Austria, Romania, Poland, the Czech Republic, Slovakia, Hungary, Bulgaria, Serbia, Bosnia, Montenegro, Albania, Kosovo, Moldova, as well as Italy and Greece.
In these markets, compliance with the European MDR Regulation is the starting point: not an advantage, but a requirement. Alfakjn manages MDR compliance and EUDAMED registration internally, providing European distribution partners with technical documentation that is always up to date and ready for local requirements.
The space for differentiation in Europe is no longer on price: it is on formulation quality, clarity of clinical positioning, and the manufacturer's operational continuity. Exactly the kind of proposition that Alfakjn brings.
- Active markets: Italy, Greece, Spain, Austria, Romania, Poland, Czech Republic, Slovakia, Hungary, Bulgaria, Serbia, Bosnia, Montenegro, Albania, Kosovo, Moldova
- Main channels: specialist distribution, modern pharmacy, hospital
- Most active therapeutic areas: joint pain, injuries and wound care, regenerative medicine
MENAT: Growing markets, focus on Made in Italy quality, premium positioning opportunities
The Middle East, North Africa and Turkey (MENAT) region represents one of the highest-growth clusters for Alfakjn. Countries such as Saudi Arabia, the UAE, Jordan and Turkey have developed increasingly structured healthcare systems, with a growing interest in medical products of certified quality and European origin.
In these markets, Made in Italy is not just a label: it is a mark of quality and reliability that healthcare professionals and hospital decision makers recognise. Alfakjn works with local partners who understand the distribution structure of their own country, from hospital tenders to private distribution networks, and supports them with technical documentation adapted to local regulatory requirements.
Regulatory management for non-EU markets is one of the strengths that our MENAT partners appreciate: no waiting for third-party updates, direct response to requests from local authorities.
- Active markets: Saudi Arabia, UAE, Jordan, Turkey
- Main channels: hospital tenders, private pharmaceutical distribution, specialist clinics
- Most active therapeutic areas: joint pain, wound care, consumer health
Ex-Soviet region: Markets with a deep medical culture, demand for innovative products, specific regulatory pathways
The former Soviet area, which includes Ukraine and Turkmenistan, has specific distribution characteristics: a highly structured medical culture, highly specialised professionals, and a distribution system that requires in-depth knowledge of local dynamics.
Alfakjn has developed relationships in this cluster through partners that combine local market knowledge with the ability to manage the specific regulatory pathways for non-EU countries. The main challenge in this area is not demand, which exists and is robust, but navigating product registration systems and distribution channels, which often vary from market to market.
Our experience in this area allows us to offer new partners a realistic picture of the timescales and requirements, without false expectations.
- Active markets: Ukraine, Turkmenistan
- Main channels: specialist distribution, hospital, outpatient network
- Most active therapeutic areas: joint pain, regenerative medicine
Asia: Vietnam, active market and growth opportunities
For Alfakjn, Vietnam represents an active market in Asia, with local partners already operational. The regulatory complexity and distribution structure of the market require a careful approach and a partner with an established local presence.
For those operating in Asia who are considering the introduction of quality European medical products, Alfakjn is available for a preliminary discussion to assess feasibility and entry timelines.
Check availability for your country
The Alfakjn team will evaluate your request. You will be contacted for an initial operational discussion based on your country, company profile, and alignment with available lines.
